Market revenue in 2023 | USD 4.7 million |
Market revenue in 2030 | USD 14.2 million |
Growth rate | 17% (CAGR from 2023 to 2030) |
Largest segment | Cytokines & growth factors |
Fastest growing segment | Cytokines & Growth Factors |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Cytokines & Growth Factors, Antibodies, Immune checkpoint proteins, Virus Antigens, Enzymes, Recombinant Regulatory Protein, Hormones |
Key market players worldwide | Thermo Fisher Scientific Inc, Danaher Corp, Bio-Techne Corp, Sino Biological, Miltenyi Biotec, Proteintech Group, Prospec, New England Biolabs |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to research-grade proteins market will help companies and investors design strategic landscapes.
Cytokines & growth factors was the largest segment with a revenue share of 21.28% in 2023. Horizon Databook has segmented the Thailand research-grade proteins market based on cytokines & growth factors, antibodies, immune checkpoint proteins, virus antigens, enzymes, recombinant regulatory protein, hormones covering the revenue growth of each sub-segment from 2018 to 2030.
Thailand is actively developing its biopharmaceutical industry, and cell therapy is one of the key focus areas. The country is investing in R&D, creating favorable policies, and building infrastructure to support the growth of the sector.
Biotechnology is designated as a priority sector for promoting post-COVID-19 recovery. The Board of Investment (BOI) authorized major projects in this field valued around THB 2.4 million (USD 0.071 million) during the first quarter of 2021.
In November 2022, the Government Pharmaceutical Organisation (GPO) of Thailand announced to initiate Phase 3 clinical trials for its COVID-19 vaccine in December, following the receipt of Phase 2 test results, anticipated by the end of the month or early next year.
Horizon Databook provides a detailed overview of country-level data and insights on the Thailand research-grade proteins market , including forecasts for subscribers. This country databook contains high-level insights into Thailand research-grade proteins market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account